| Financial Year |
March 31 2023 |
| Monetary Funds |
2,506,755,659.39 |
| Held-for-trading Financial Assets |
560,703,156.45 |
| Notes Receivable |
2,650,516,712.53 |
| Accounts Receivable |
3,503,222,486.84 |
| Advances to Suppliers |
1,394,809,343.12 |
| Other Receivables |
143,849,154.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,169,641,894.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
98,650,974.10 |
| Total Current Assets |
17,884,022,676.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,889,209.60 |
| Long-term Equity Investment |
67,186,449.46 |
| Investment Properties |
-- |
| Fixed Assetes |
2,315,910,456.47 |
| Under-construction Projects |
73,553,025.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
445,786,326.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,257,652.58 |
| Deferred Income Tax Assets |
397,603,952.78 |
| Other Non-Current Assets |
330,966,544.76 |
| Sub-Total of Non-Current Assets |
3,653,323,101.32 |
| Total Assets |
21,537,345,778.21 |
| Short-Term Loans |
9,959,120.83 |
| Trading Financial liabilities |
425,266.17 |
| Notes Payable |
2,417,181,244.09 |
| Accounts Payable |
3,927,364,721.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,681,574.46 |
| Taxes Payable |
84,943,726.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,161,630.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,067,288.18 |
| Other Current Liabilities |
402,388,657.52 |
| Sub-Total of Current Liabilities |
13,280,233,338.28 |
| Long-term Loans |
888,240,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
448,608,542.44 |
| Deferred Income Tax Liabilities |
5,707,111.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,468,989,390.19 |
| Total Liabilities |
14,749,222,728.47 |
| Paid-In Capital(Or Share Stock) |
1,931,370,032.00 |
| Capital Surplus |
2,329,474,681.36 |
| Surplus Reserve |
268,119,146.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,338,979,999.55 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,788,123,049.74 |
| Owner's Equity（Stockholder's Equity） |
6,788,123,049.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,537,345,778.21 |
